1. Bagi, Z., Koller, A. and Kaley, G. (2004). PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 286: H742-H748.
2. PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
3. Barton, M., Haudenschild, C.C., d'Uscio, L.V., Shaw, S., Munter, K. and Luscher, T.F. (1998). Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA. 95: 14367-14372.
4. Berger, J.P., Akiyama, T.E. and Meinke, P.T. (2005). PPARs: therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 26: 244-251.
5. The Mechanisms of Action of PPARs